Germany - medicaments

Description

Due to the existence of industrial property rights with regard to the contractual active ingredient, the participation and contractual documents will only be made available to pharmaceutical companies that offer/commercialize drugs for the contractual active ingredient or that The present announcement does not concern the award of a public contract within the meaning of the Public Procurement Directive (2014/24/EC) or the Antitrust Procurement Act (Kartellvergaberechts) within the meaning of Annex 4 to the contract (self-declaration of approval and of the company). In the interest of providing interested pharmaceutical companies with the broadest possible information, this notice is published in the Supplement to the Official Journal of the European Union. The procedural designation "Open Procedure" in accordance with Section IV.1.1) and the indication of the award criteria in accordance with Section II.2.5) used in the present notice text are owed to the specifications of the notice form and have no further meaning. Herewith as well as with the use of the medium "TED" no submission is connected under procurement law regulations, whose validity is not obligatorily given by law and/or award regulations.

Opportunity closing date

31 December 2021

Value of contract

to be confirmed